September 14, 2022 — Minimally invasive, catheter-based transcatheter aortic valve replacement (TAVR) has revolutionized treatment of aortic stenosis (AS), and both American and European guidelines have approved its use. However, there is a perception that TAVR is more expensive than surgical aortic valve replacement (SAVR).

September 14, 2022 — GE Healthcare and Lantheus Holdings Inc have announced that the recent Phase III clinical trial of their investigational radiotracer, [18F]flurpiridaz, has met its co-primary endpoints of exceeding a 60 percent threshold for both sensitivity and specificity for detecting 

September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of Johnson & Johnson MedTech†, released findings from an AFib PulseCheck Survey that reveals AFib patient behaviors and their understanding of AFib treatment optio

September 14, 2022 — Details on late-breaking clinical trials to be presented during The VEINS (Venous Endovascular INterventional Strategies) and VIVA  (Vascular InterVentional Advances) Annual Conference have been announced.

September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, has announced that the U.S.

September 13, 2022 — ZOLL Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in the AMIHOT III post-approval study further evaluating 

September 13, 2022 — The ŌNŌ endovascular retrieval system was recently used to remove a malpositioned leadless pacemaker (LPM) that embolized to the right pulmonary artery in a 52- year-old patient, ŌNŌCOR LLC announced.

September 13, 2022 — The latest expert consensus document from the Society of Cardiovascular Computed Tomography (SCCT), co-published with EuroIntervention, describes Coronary CT Angiography (CCTA) as an effective tool for interventional cardiologists to prepare and optimize the coronary procedure.

DAIC editors outline some highlights of what to expect from this year’s conference.

The Transcatheter Cardiovascular Therapeutics (

September 12, 2022 — Researchers at the National Institutes of Health have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now